Not known Factual Statements About ABBV-744 preclinical studies and results
Participant consumed grapefruit or grapefruit goods within three times previous to the 1st dose of study drug.- "Our study uncovered the vital position on the KLF16/MYC regulatory axis in modulating tumor progress and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, for example OTX015 or ABBV-744, with DDP or gemc